Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,056 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Productive Syntheses of Privileged Scaffolds Inspired by the Recognition of a Diels-Alder Pattern Common to Three Classes of Natural Products.
Badarau E, Reddy KHV, Loudet A, Simon C, Trembleau L, Claerhout S, Pair E, Massip S, Breton P, Lesur B, Goldstein S, Fourquez JM, Henlin JM, Ghosez L. Badarau E, et al. Among authors: goldstein s. Chemistry. 2020 Dec 1;26(67):15477-15481. doi: 10.1002/chem.202002372. Epub 2020 Sep 17. Chemistry. 2020. PMID: 32428343
Preparation and affinity profile of novel nicotinic ligands.
Charton Y, Guillonneau C, Lockhart B, Lestage P, Goldstein S. Charton Y, et al. Among authors: goldstein s. Bioorg Med Chem Lett. 2008 Mar 15;18(6):2188-93. doi: 10.1016/j.bmcl.2007.12.075. Epub 2008 Jan 26. Bioorg Med Chem Lett. 2008. PMID: 18262785
Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D, Newman-Tancredi A, Quentric Y, Carpentier N, Poissonnet G, Parmentier JG, Goldstein S, Millan MJ. Cussac D, et al. Among authors: goldstein s. Naunyn Schmiedebergs Arch Pharmacol. 2002 Mar;365(3):242-52. doi: 10.1007/s00210-001-0505-y. Epub 2002 Jan 16. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 11882920
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population.
Maglalang PD, Sinha J, Zimmerman K, McCann S, Edginton A, Hornik CP, Hornik CD, Muller WJ, Al-Uzri A, Meyer M, Chen JY, Anand R, Perrin EM, Gonzalez D; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Maglalang PD, et al. Clin Pharmacokinet. 2024 May 30. doi: 10.1007/s40262-024-01367-2. Online ahead of print. Clin Pharmacokinet. 2024. PMID: 38814425
3,056 results